Persistent Sleep

Related by string. * PERSISTENT . persistent : persistent pulmonary hypertension . Persistent Organic Pollutants . Persistent Organic Pollutants POPs . persistent violator . persistent drizzle . persistent cough / sleeps . sleeping . Sleeping . Sleeper . sleeper : Money Never Sleeps . Sleeping Beauty Castle . sleep disordered breathing . Lion Sleeps Tonight . sleeping bags * *

Related by context. Frequent words. (Click for all words.) 60 Secondary endpoints include 60 Montgomery Asberg Depression 59 Secondary endpoints included 59 Rating Scale MADRS 58 Alzheimer Disease Assessment 58 hemoglobin A1c HbA1c 58 Health Assessment Questionnaire 57 Severity Index PASI 57 Main Outcome Measures 57 apolipoprotein B 57 lispro 57 cell adhesion molecule 56 Scale PANSS 56 #mg/day [001] 56 exhaled nitric oxide 56 estimated glomerular filtration 55 Psoriasis Area 55 fasting plasma glucose FPG 55 glomerular filtration rate 55 C Reactive Protein 55 tapentadol ER 55 noradrenergic 54 serum potassium 54 serum concentrations 54 Secondary endpoints 54 Acetate Rectal Suppositories 54 Visual Analog Scale 54 International Prostate Symptom 54 Negative Syndrome 54 HBsAg 54 pharmacodynamic effects 54 Stress Testing 54 CIMZIA TM 54 mg QD 53 APTIVUS r 53 P = .# 53 lopinavir r arm 53 Unified Parkinson Disease 53 locomotor activity 53 alanine aminotransferase 53 baseline HbA1c 53 mL kg 53 NPH insulin 53 OGTT 53 platelet reactivity 53 transient insomnia 53 systolic ejection 53 annualized relapse 53 Spirometry 53 severe neutropenia 53 hypophosphatemia 53 corticosteroid therapy 52 Holter monitoring 52 clinically meaningful improvement 52 statistically significant reduction 52 apnea hypopnea index 52 CrCl 52 Expanded Disability Status 52 Cmax 52 carotid intima media 52 ADAS cog 52 left ventricular systolic 52 pharmacokinetic parameters 52 spontaneous bowel movements 52 erythrocyte sedimentation rate 52 placebo p = 52 tirofiban 52 Systolic 52 TAXUS p value 52 CK MB 52 administered subcutaneously 52 CDAI 51 Angiographic 51 Pegasys ® 51 PT INR 51 g trans fats 51 lipopolysaccharide 51 PANSS 51 #mg/m# [002] 51 posttreatment 51 plasma concentrations 51 insulin detemir 51 Intranasal 51 #mg/m# [001] 51 polysomnography 51 methacholine 51 sweat chloride 51 sustained virological response 51 intravenously administered 51 P selectin 51 QTc prolongation 51 pharmacokinetics PK 51 lanthanum carbonate 51 fraction LVEF 51 #mg/kg [002] 51 Disease Activity 51 SpO2 51 bronchoconstriction 50 antiviral efficacy 50 DAS# [002] 50 VKORC1

Back to home page